CXCR2 and Alzheimer disease: Treatment of human brain microvascular endothelial cells with Aβ results in increased expression of CXCR2 which, via interaction with CXCL1, is involved in the breakdown of the BBB integrity and increased migration of monocytes into the brain of AD patients (Zhang et al. 2013).